Table 7 Analysis of disproportionality focusing on adverse events related to general disorders and conditions at the administration site.
| Â | ROR (95% CI) | PRR (95% CI) |
|---|---|---|
Viloxazine | 0.49(0.43–0.56) | 0.55(0.43–0.56) |
Dextroamphetamine | 2.00(1.79–2.34) | 1.81(1.79–2.33) |